New website to chronicle Australians' engagement in science
03 February, 2014From today, Australian communication researchers will be able to monitor more closely what science Australians are being exposed to, with the launch of a new website chronicling science engagement activities across the country.
Burnet Institute to roll out cheap point-of-care HIV test
30 January, 2014Burnet Institute has received US$1.6 million from UNITAID to begin evaluation studies of HIV test VISITECT CD4 in India and South Africa. The point-of-care test uses a small amount of blood from a finger prick to determine when an HIV-positive patient should start lifesaving treatment. Results of the test are available after 40 min at a cost of approximately $5.
Westlab 2014-2015 laboratory catalogue
28 January, 2014 | Supplied by: Westlab SuppliesWestlab has launched its 2014-2015 laboratory catalogue.
ANSTO celebrates the International Year of Crystallography
23 January, 2014The study of crystallography - the only technique for examining the arrangement and structure of matter or materials at the atomic or molecular level - is around 100 years old. In light of this, the United Nations Educational, Scientific and Cultural Organisation (UNESCO) has declared 2014 the International Year of Crystallography (IYCr2014).
2014 Australian Academy of Science award winners announced
23 January, 2014The Australian Academy of Science has announced this year's winners of its prestigious annual awards for scientific excellence. As Academy President Professor Suzanne Cory explained, "These awards celebrate both career-long contributions by some of Australia's most distinguished researchers and remarkable discoveries made by younger investigators."
University of Melbourne and Sanofi Pasteur to develop human vaccines
22 January, 2014Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university's commercial engagement services company.
Federal funding to fight cancer and other diseases
21 January, 2014The federal government has awarded $8 million to three La Trobe University scientists for research into next-generation immunological and plant-based therapies for cancer and other diseases.
Bioluminescence alliance receives ARC Linkage Grant
21 January, 2014A team of world leaders in the field of biomolecular interaction, relating to basic biomedical research and the discovery of new pharmaceuticals, has been the recipient of an Australian Research Council (ARC) Linkage Grant.
Lonza partners with Pharmacyclics to produce oncology drug
16 January, 2014Lonza, a supplier in chemical development and manufacturing, has established an agreement with Pharmacyclics to support the commercial and clinical production of its oral oncology drug Imbruvica (Ibrutinib).
TTP Labtech acquires fluorescence lifetime technology
13 January, 2014TTP Labtech has consolidated its position in the field of fluorescence lifetime (FLT) technology, having recently purchased assets from UK-based FLT company AssayMetrics.
IFCC certifies EKF Diagnostics point-of-care analyser
10 January, 2014Global diagnostics company EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyser has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification.
US EPA contracts Stemina for toxicology tests
10 January, 2014Stemina Biomarker Discovery, a company whose cell-based tests combine stem cells and metabolomics, has been awarded a contract by the US Environmental Protection Agency (EPA) under its ToxCast initiative.
3D electromaterials centre to be established
10 January, 2014The ARC Centre of Excellence for Electromaterials Science (ACES) has received $25 million to further develop work on smart nanomaterials by creating 3D devices with capabilities more advanced than those of their 2D counterparts.
Continuous glucose monitoring market report released
20 December, 2013Allied Market Research (AMR) has released a market research report analysing current and future trends in the continuous glucose monitoring (CGM) market from 2012 to 2020. The report projects that the CGM market will reach $568.5 million by 2020 from its 2012 value of $194.8 million.
Grace granted Australian patent for flash chromatography technology
18 December, 2013WR Grace & Co has announced that the Australian Patent Office has granted a patent related to the company's Reveleris flash chromatography system. The patent concerns the use of evaporative light scattering detection (ELSD) with flash chromatography, which is a key component of the Reveleris flash chromatography system.
